Brief: Pharnext H1 Net Loss Widens At 12.3 Millions Euros
Oct 16 (Reuters) - PHARNEXT SA PHARN.PA :
* PHARNEXT ANNOUNCES 2019 HALF-YEAR RESULTS
* H1 NET LOSS EUR 12.3 MILLION VERSUS LOSS OF EUR 8.3
MILLION YEAR
AGO
* H1 OPERATING LOSS EUR 10.2 MILLION VERSUS LOSS OF EUR 7.4
MILLION YEAR AGO
* H1 NET CASH FLOW EUR 1.9 MILLION VERSUS EUR 5.7 MILLION
YEAR AGO
Source text for Eikon: ID:nEQ9cs2lZa
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development